|
11.01.2024 17:34:43
|
EQS-AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
|
EQS Preliminary announcement financial reports: Biotest AG
/ Preliminary announcement on the disclosure of financial statements
Biotest AG hereby announces that the following financial reports shall be disclosed for the business year 2023:
Report Type: Annual financial report Language: German Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/geschaeftsberichte.cfm Language: English Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/annual_reports.cfm Report Type: Annual financial report of the group Language: German Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/geschaeftsberichte.cfm Language: English Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/annual_reports.cfm
11.01.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Biotest AG |
| Landsteinerstraße 5 | |
| 63303 Dreieich | |
| Germany | |
| Internet: | www.biotest.de |
| End of News | EQS News Service |
|
|
1813427 11.01.2024 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biotest AG Vz.mehr Nachrichten
Analysen zu Biotest AG Vz.mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.